Rankings
▼
Calendar
ESLA Q3 2021 Earnings — Estrella Immunopharma, Inc. Revenue & Financial Results | Market Cap Arena
ESLA
Estrella Immunopharma, Inc.
$53M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$108,110
Net Income
-$107,547
EPS (Diluted)
$-0.02
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$15,984
Free Cash Flow
-$15,984
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$46M
Total Liabilities
$2M
Stockholders' Equity
$44M
Cash & Equivalents
$772,168
← FY 2021
All Quarters
Q4 2021 →
